Terms: = Ovarian cancer AND COX6C, P09669, 1345, ENSG00000164919 AND Prognosis
1 results:
1. Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.
Heitz F; Harter P; Åvall-Lundqvist E; Reuss A; Pautier P; Cormio G; Colombo N; Reinthaller A; Vergote I; Poveda A; Ottevanger PB; Hanker LC; Leminen A; Alexandre J; Canzler U; Sehouli J; Herrstedt J; Fiane B; Merger M; du Bois A
Gynecol Oncol; 2019 Feb; 152(2):235-242. PubMed ID: 30466805
[TBL] [Abstract] [Full Text] [Related]
